Florida Cancer Specialists partners with Cedar to improve the patient financial experience
Personalized billing and payment platform will enable an improved financial experience for oncology patients across the growing FCS community-based provider network.
NEW YORK — Florida Cancer Specialists & Research Institute (FCS) and Cedar, a patient engagement and payment technology platform, today announced that they are partnering to modernize the on-line payment experience for FCS patients.
“This partnership with Cedar enables us to keep pace with the rapid technology advances in the healthcare industry and improve the patient experience,” said FCS CEO Brad Prechtl, MBA. FCS is dedicated to providing world-class cancer care to patients in convenient locations close to their homes.
Cedar’s patient payment and engagement platform offers a seamless, intuitive user experience and enables customized outreach, messaging and bill resolution to patients based on a variety of unique factors and preferences. Aligned to the FCS commitment to excellence, Cedar’s platform receives patient satisfaction scores averaging 95%.
“Cedar provides a personalized platform that is easy and convenient for our patients and their families,” said FCS Chief Revenue Cycle Officer Sarah Cevallos. “It will streamline the often-cumbersome payment process.”
“At Cedar, we are working to help providers rise to meet healthcare consumers’ heightened expectations and offer an exceptional financial experience,” said Cedar Co-founder and CEO Florian Otto. “Florida Cancer Specialists is on the forefront of this trend and is driving change on behalf of their physicians and patients in ways that are beneficial to all.”
About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. In the past four years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Trained in prestigious medical schools and research institutes, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.
Founded in 1984, Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy. Our highest values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians and staff.
*Prior to approval
Cedar is a patient payment and engagement platform for hospitals, health systems and medical groups that elevates the total patient experience beyond clinical care. The platform leverages advanced data science and smart segmentation to deliver modern intelligence and simplify the healthcare experience for patients. To learn more, visit www.cedar.com
For Florida Cancer Specialists